Analyst picks & changes
Interneuron Pharmaceuticals Inc.
(IPIC)
Patricia Lea of Argo Analysis said she thinks it likely that IPIC's dexfenfluramine anti-obesity drug will be approved. The Lexington,
Gathering data...
Interneuron Pharmaceuticals Inc.
(IPIC)
Patricia Lea of Argo Analysis said she thinks it likely that IPIC's dexfenfluramine anti-obesity drug will be approved. The Lexington,